Synimed, manufacturer of SYNICEM™ joins the Biocomposites Group
In 2022, Synimed became part of the Biocomposites Group. Bringing together Synimed’s SYNICEM product range and Biocomposites products, created an unrivalled portfolio of pioneering products for use in bone and soft tissue infection. Based in Keele, UK, with global operations across Europe, USA, Canada, Argentina, China, India and Italy our specialist calcium compounds, bone cements and polymer related products are used in over 1 million procedures in 100 countries every year.